window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : July 28, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

antisense oligonucleotides

  • Clinical & Regulatory,Manufacturing & Supply Chain,Pharmaceuticals and therapeutics

    ten23 health secures Swissmedic ATMP manufacturing licences

    ten23 health has obtained Good Manufacturing Practice (GMP) licences from [...]

    June 30, 2026
  • Advanced Therapies,Biotech & Pharma Business,Drug Discovery & Development,Genomics and sequencing,Therapeutic Areas

    PacBio HiFi adopted to study sudden unexplained death in childhood and advance precision therapies for rare diseases

    PacBio is supporting two research initiatives that use its HiFi [...]

    May 5, 2026
  • Drug Discovery & Development

    Hongene to supply exNA oligonucleotide technology under new licensing deal

    Hongene Biotech Corporation, a contract development and manufacturing organization (CDMO) [...]

    May 5, 2026

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Pioneer launches regional accelerator programmes for life science and tech start-ups
    Categories: Biotech & Pharma Business, Drug Discovery & Development, Manufacturing & Supply Chain, Medical devices, Research & Development
  • Fetal medicine pioneer recognised for expanding access to ultrasound education
    Categories: Clinical & Regulatory, Medical devices, Opinion & Events, Research & Development
  • Opella invests $70m in Mexico to expand Enterogermina production
    Categories: Biotech & Pharma Business, Manufacturing & Supply Chain, Pharmaceuticals and therapeutics
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top